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ABSTRACT
Background and Objectives: Gallstones are twice as com-
mon in cirrhotic patients as in the general population. Al-
though laparoscopic cholecystectomy (LC) has become the
gold standard for symptomatic gallstones, cirrhosis has been
considered an absolute or relative contraindication. Many
authors have reported on the safety of LC in cirrhotic pa-
tients. We reviewed our patients retrospectively and as-
sessed the safety of LC in cirrhotic patients at a tertiary care
hospital in Pakistan.
Methods: From January 2003 to December 2005, a retro-
spective study was conducted at SU IV, Liaquat University of
Medical & Health Sciences Jamshoro. All the cirrhotic pa-
tients with Child-Pugh class A and B cirrhosis undergoing LC
were included in the study. Cirrhosis was diagnosed based
on clinical, biochemical, ultrasonography, and intraoperative
findings of the nodular liver and histopathological study.
Results: Of 250 patients undergoing laparoscopic cholecys-
tectomy, 20 (12.5%) were cirrhotic. Of these 20, 12 (60%)
were Childs group A and 8 (40%) were group B. Thirty
percent were hepatitis B positive, and 70% were hepatitis C
positive. Preoperative diagnosis of cirrhosis was possible in
80% of cases, and 20% were diagnosed during surgery.
Morbidity rate was 15% and mortality rate was 0%. Two
patients developed postoperative ascites, and mean hospital
stay was 2.80.1 days. Of the 20 cases, 2 (10%) were con-
verted to open cholecystectomy. The mean operation time
was 70.232.54 minutes.
Conclusion: Laparoscopic cholecystectomy is an effective
and safe treatment for symptomatic gallstone disease in se-
lect patients with Child-Pugh A and B cirrhosis. The advan-
tages over open cholecystectomy are the lower morbidity
rate and reduced hospital stay.
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INTRODUCTION
Chronic liver disease is a major health problem in Paki-
stan. The most common cause is viral hepatitis B and C,
which is now endemic in Pakistan. According to one
study,1 4.3% of the population is sero-positive for hepatitis
B surface antigen and 6% for hepatitis C antibodies. This
results in an increasing number of patients who ultimately
will develop cirrhosis.
Gallstones are twice as common in cirrhotic patients as in
the general population.2–4 With this increase in the prev-
alence in viral hepatitis, surgeons now more frequently
encounter cirrhotic patients with symptomatic gallstones.
Since the introduction of laparoscopic cholecystectomy in
the United States in 1988, it has become the gold-standard
treatment for symptomatic gallstones. Postoperative mor-
bidity and mortality rates are significantly lower with LC
compared with those for open cholecystectomy. Although
laparoscopic cholecystectomy has become the treatment
of choice, cirrhosis has been considered an absolute or
relative contraindication.5 However, with surgeons’ in-
creased experience in laparoscopic surgery, it has been
shown to be safe and well tolerated in cirrhotic patients.
Several studies have reported the efficacy and safety of
laparoscopic cholecystectomy in cirrhotic patients.6–11
The aim of our study was to assess the safety of laparo-
scopic cholecystectomy in cirrhotic patients and to eval-
uate its benefits compared with the benefits in noncir-
rhotic patients.
PATIENTS AND METHODS
From January 2003 to December 2005, a total of 250
patients underwent laparoscopic cholecystectomy for
symptomatic gallstone disease in our unit. Of these 250
patients, 20 had cirrhosis. All of these patients provided a
medical history followed by a physical examination, ul-
trasonography, liver function tests, prothrombin time,
platelet count, and viral hepatitis screening. The diagnosis
of cirrhosis was made based on preoperative workup,
intraoperative findings of a nodular liver, and histopatho-
logical study. All patients were evaluated preoperatively
according to the American Society of Anesthesiologists
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SCIENTIFIC PAPER(ASA) scoring system. Laparoscopic cholecystectomy was
performed with the standard 4-port technique with the
patient under general anesthesia. Pneumoperitoneum was
created through the first port subumbilically by means of
the open (Hassan) technique. A subhepatic drain was
kept in place in all cases.
The data were analyzed for patient demographics, labo-
ratory findings, cause of cirrhosis, Child-Pugh class, oper-
ative time, conversion rate, procedure-related morbidity,
and mortality and hospital stay. The data were evaluated
by using SPSS version 16.0. Fisher’s exact test and Pear-
son’s chi-square test were applied for categorical param-
eters, and the independent t test was used to compare the
means (2-tailed) among continuous variables. The results
were calculated on 95% confidence interval. P0.05 was
considered significant.
RESULTS
Twenty patients with cirrhosis, 3 males and 17 females,
underwent laparoscopic cholecystectomy. Mean age of
the patients was 43.98.06, whereas mean age of noncir-
rhotic patients (n230) was 43.57.28.
Of these 20 patients, cirrhosis was diagnosed as secondary
to hepatitis C in 14 (70%) patients and hepatitis B in 6
(30%) patients. Child-Pugh classification was used to as-
sess the severity of liver cirrhosis; 12 (60%) patients were
class A, and 8 (40%) were class B.
Two (10%) patients in the cirrhotic group and 15 (6.5%) in
the noncirrhotic group had a history of previous abdom-
inal surgery. Significant comorbidity was present in 4
(20%) cirrhotic patients and 20 (8.7%) noncirrhotic pa-
tients (Table 1).
Table 2 shows the laboratory data collected before sur-
gery. Elevated levels of total bilirubin, aspartate amino-
transferase (AST), alanine aminotransferase (ALT), and
lower albumin were noted in patients with cirrhosis.
The mean operation time was 70.232.54 minutes in
patients with cirrhosis, significantly longer compared with
operative time for patients without cirrhosis. Conversion
to an open procedure was required in 2 (10%) patients
because of hemorrhage in the liver bed. The mean length
of hospital stay was 2.80.1 days, not much different from
that for noncirrhotic patients (Table 3).
No operative mortalities occurred. Postoperative morbid-
ity was observed in 3 (15%) patients with cirrhosis (Table
3). Postoperative complications for each group are pre-
sented in Table 4. Two patients with Child-Pugh class B
cirrhosis developed ascites after surgery; one patient with
Child-Pugh class A had bile leakage. All patients were
followed up for 2 years.
DISCUSSION
Gallstone disease is a prevalent disease worldwide and
more common in patients with cirrhosis of the liver. Its
incidence is 29.4% for patients with cirrhosis compared
with 12.8% for patients without cirrhosis.2,12 According to
a study13 conducted at a teaching hospital, in Pakistan,
the frequency of gallstones is 31%. Pathogenic factors
seem to be responsible for the high incidence of gallstones
in cirrhosis including intravascular hemolysis, hyper-
splenism, reduction in biliary acidity, increased levels of
estrogen, and functional alterations of the gallbladder (re-
duction in motility and emptying). Several published re-
ports have shown that cirrhosis of the liver has a major
Table 1.
Patient Demographics (n  250)
Cirrhotic (n  20) Noncirrhotic (n  230) P Value
Age (in years) 43.9  8.06 43.5  7.28 0.82
Sex
Male
Female
Child Pugh Class
A
B
Hepatitis B Positive
Hepatitis C Positive
Previous Abdominal Operation
Associated Disease
3 (15.0%)
17 (85.0%)
12 (60.0%)
8 (40.0%)
6 (30.0%)
14 (70.0%)
2 (10.0%)
4 (20.0%)
22 (9.6%)
208 (90.4%)
-
-
-
-
15 (6.5%)
20 (8.7%)
0.4
 0.001*
 0.001*
 0.001*
0.63
0.11
* P value is statistically significant.
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tomy. Because of the high rates of mortality (83.3%) and
morbidity, Aranha et al14 considered cholecystectomy in
patients with cirrhosis as “a formidable operation.” The
main complications of open cholecystectomy in cirrhotic
patients are ascites, wound and pulmonary infection, and
hemorrhage. By the late 1980s, better surgical results have
been published for cirrhotic patients with normal hepatic
synthetic function who underwent elective cholecystec-
tomy.
Laparoscopic cholecystectomy has been proven safe and
feasible for symptomatic gallstones, but its role in cirrhotic
patients remains controversial. Yerdel et al10 in 1993 re-
ported the first study of laparoscopic cholecystectomy in
cirrhosis. Although a small number of patients were in-
cluded in the study, no morbidity or mortality occurred.
However, with surgeons’ increase in laparoscopic experi-
ence, various recent studies have demonstrated that lapa-
roscopic cholecystectomy in cirrhosis is safer and better
tolerated than open cholecystectomy. Proper patient se-
lection after estimating the risk is an essential requirement.
The Child-Pugh classification is helpful in estimating the
Table 2.
Patient Laboratory Data (n  250)
Cirrhotic (n  20)* Noncirrhotic (n  230)* P Value
While Blood Cells (L)
Albumin (g/dL)
Bilirubin
Creatinine
AST (IU/L)
ALT (IU/L)
ALP (IU/L)
Prothrombin Time
6525.00  1098.7
3.01  0.5
1.22  1.3
1.03  0.25
69.5  75.2
67.5  80.0
93.2  52.6
16  3.0
6711.30  953.620
4.21  0.81
1.02  1.29
1.36  3.51
34.5  55.0
39.8  70.2
83.2  72.2
12  1.0
0.4
0.003
0.12
0.03
0.001
0.0006
0.087
0.001
*Results are expressed as mean  standard deviation.
Table 3.
Surgical Outcomes After Laparoscopic Cholecystectomy (n  250)
Cirrhotic (n  20)* Noncirrhotic (n  230)* P Value
Operation time (minutes)
Hospital stay (in days)
70.2  32.54
2.8  1.19
53.9  4.56
2.8  1.16
 0.001*
0.86
Conversion Rate
Morbidity
Mortality
2 (10.0%)
3 (15.0%)
0
10 (4.3%)
44 (19.1%)
0
0.24
1.00
0
*Results are expressed as mean  standard deviation.
Table 4.
Causes of Morbidity (n  250)
Cirrhotic (n  20) Noncirrhotic (n  230)
Wound Infection
CBD Injury
Residual CBD Stone
Bile Leakage
Trocar Site Hematoma
Intraabdominal Abscess
Ascites
0
0
0
1 (5.0%)
0
0
2 (10.0%)
8 (3.5%)
0
0
2 (0.9%)
4 (1.7%)
4 (1.7%)
2 (.9%)
*CBD  common bile duct.
†P value  0.01.
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The need for blood transfusion and patient mortality and
morbidity all correlate with the Child-Pugh classification.
Block et al17 reported a mortality of 27% among Child-
Pugh C, 9% among Child-Pugh B, and no mortality among
Child-Pugh A patients. Kogut et al18 also reported a zero
percent mortality among Child-Pugh A patients, and Wu et
al19 suggested that Child-Pugh A patients can even be
regarded as “noncirrhotic” in biliary surgery.
We performed LC only on patients with Child-Pugh class
A and B cirrhosis. Those classified as Child-Pugh class C
were referred to the medical team for conservative man-
agement. A similar approach was used by investigators in
a recent study carried out at a tertiary care hospital in
Pakistan.20 The literature also shows a prevalence of
Child-Pugh A patients, whereas only a few studies report
Child-Pugh C patients, and it is impossible to draw a
conclusion about these very high-risk patients.12
Our study reflects the patient population at our hospital.
Hepatitis B and C were the leading causes of cirrhosis in
our patients, which is contradictory to reports in the liter-
ature, which indicate that alcoholic liver disease is more
prevalent in the West. In our setting, chronic liver disease
due to viral hepatitis is common; therefore, abnormal
laboratory data raised the suspicion of cirrhosis, and we
further investigated our patients to reach a final diagnosis.
Most of the patients in our study were diagnosed preop-
eratively and confirmed by intraoperative liver biopsy.
This is in contrast to previous reports where many patients
were found to have cirrhosis incidentally at the time of
laparoscopic cholecystectomy.20–22 Hamid et al23 recom-
mend that in areas where liver disease is prevalent, all
patients undergoing surgery should have prothrombin
time, serum albumin, hepatitis B surface antigen, and
careful abdominal ultrasound with particular emphasis on
the liver. The results of laboratory data in our series are
similar to that reported by Yeh et al24 and differ from the
results reported in Fernandes et al’s25 control study.
Mean operation time in our study was 70.2 minutes, which
is significantly shorter than that reported in the earlier
literature. Our study showed an increased conversion rate
to open cholecystectomy that differs from previous pub-
lished data. In the literature, the conversion rate of lapa-
roscopic cholecystectomy in cirrhotic patients ranged
from 0% to 9%.10,11 However, a 0% conversion rate was
reported in some small series containing less than 10
patients that might indicate selected patients in the series.
The mean hospital stay was 2.8 days, similar to that in
patients without cirrhosis. However, Puggioni and
Wong26 in their metaanalysis reported that operative time
and length of hospital stay in cirrhotic patients were con-
siderably reduced for laparoscopic cholecystectomy com-
pared with the open approach.
The morbidity rate in this study was 15%. The main com-
plication in our series was ascites and bile leakage, which
were managed conservatively. The incidence of ascites
after open cholecystectomy is unknown. Brown and
Burk27 reported a 39% rate of ascites after exploratory
laparotomy for various indications in cirrhotic patients.
Several causes are postulated, such as leakage of lym-
phatic vessels interrupted at surgery, gallbladder bed lym-
phatics, and blood loss.
Based on previous published reports,21,22 it is evident that
bleeding complications are more common in patients with
cirrhosis. To avoid these complications in patients with
cirrhosis, we used a Harmonic scalpel during surgery
while dissecting the gallbladder from the liver bed. The
bleeding that occurs during gallbladder dissection is usu-
ally venous and can easily be controlled. In case of trou-
blesome bleeding, Spongstan can be used. If the blood is
spurting then a figure of eight stitch can be applied.
Because of the anticipated difficulties during surgery in
patients with cirrhosis, particular care is necessary. The
surgeon should avoid excessive traction on the gallblad-
der. In cases where there is uncontrolled bleeding or
difficulty in retraction of the liver, we advise insertion of
additional ports.
Results of several studies have been published that show
encouraging outcomes with laparoscopic cholecystec-
tomy in cirrhotic patients. Laparoscopic cholecystectomy
offers several advantages over open cholecystectomy in-
cluding less bleeding, lower morbidity, and shorter hos-
pital stay. Blood loss is reduced because magnification of
the surgical field permits meticulous dissection of the
gallbladder and a hemostasis role for pneumoperitoneum
(barohemostasis).10,28
In addition, laparoscopy avoids the subcostal incision that
would increase hemorrhage in patients with cirrhosis.
Another advantage of this approach is the lower chance of
postoperative adhesion, which is beneficial for patients
who may have a liver transplant in the future.7
Morino et al13 also note that laparoscopic cholecystectomy
has distinct advantages for the surgical team. Laparoscopy
reduces the risk of contamination, especially in treatment
of patients with hepatitis B and C related cirrhosis.
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Based on our results as well as those of others, we con-
clude that laparoscopic cholecystectomy is an effective
and safe treatment for symptomatic gallstone disease in
select patients with Child-Pugh A and B cirrhosis. How-
ever, appropriate preoperative preparations and careful
intraoperative techniques are required for better out-
comes. LC has the advantages over open cholecystectomy
of lower morbidity and reduced hospital stay.
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